Labiotech.eu

News and Trends 11 Oct 2016

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

Crescendo Biologics, a small UK-based startup, has made an almost €1B deal with Japanese giant Takeda for its Humabody technology. Crescendo Biologics may seem like a small fish, but it has caught the attention of a host of blue-chip investors like Sofinnova Partners. Its Humabody platform has recently attracted the Japanese pharmaceutical giant, Takeda, whose subsidiary, […]

October 11, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 11 Oct 2016

World Mental Health Day: How is Biotech Helping the Cause?

Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental Health Day yesterday, we want to share with you some of the latest technologies that address these conditions. Yesterday, October 10th, was World Mental Health Day: it is dedicated to raising awareness of neurological and mental disorders […]

October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Oct 2016

Big Pharmas Battle to be the Lung Cancer Leader at ESMO

Merck, Roche and BMS have unveiled updated results in Copenhagen as the companies duke it out for the leadership in lung cancer therapies. The conference of the European Society of Medical Oncology (ESMO) is underway in Copenhagen, and big pharma’s efforts to cure lung cancer are stealing the show. Three titans, Roche (Genentech), Merck and […]

October 10, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 10 Oct 2016

Overseas Deaths in the Clinic come as a Blow to Boehringer Ingelheim

Boehringer Ingelheim has swiftly dumped its olmutinib collaboration with Hanmi following news of deaths in South Korean Phase II trials. An investigation by the South Korean Ministry of Food and Drug Safety has linked several deaths to olmutinib, a lung cancer drug launched by Hanmi. Sound familiar? Boehringer Ingelheim just signed a deal to acquire the […]

October 10, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 10 Oct 2016

The CRISPR Revolution is here, but how can we make it Useful?

By this point, you can’t have escaped hearing about CRISPR. First discovered in the 1980’s, the repeated sequences and their function in bacterial defense systems remained a mystery until almost 10 years ago, when it was hailed as the biggest scientific discovery of the century. Since then, scientists have leveraged the adaptable, heritable mechanism to develop the most powerful gene-editing technology […]

October 10, 2016 - 6 minutesmins - By External Contributor

News and Trends 10 Oct 2016

Meet the French CEO who wants to Break Barriers to Drug Delivery

The objective of the French biotechnology company, Vect-Horus, is to leverage its technology, VECTrans, to facilitate the delivery of drugs into the brain and other organs. For this innovation, the company recently received the Frost & Sullivan 2016 Leadership award, which independently recognizes companies for demonstrating excellence in developing innovative technologies and practices within an industry. […]

October 10, 2016 - 5 minutesmins - By Marie Godar

News and Trends 8 Oct 2016

Microbial Donuts at the Vienna Design Week, fancy a bite? Here’s the Recipe!

This week’s bioartist has a very sweet exhibition at the Vienna Design Week. Taylor Caputo has traveled from the other side of the pond to showcase her current project: custom donuts engineered with synthetic biology. Six talented artists are showing their work at Possible Tomorrows, an exhibition at the Vienna Design Week that combines art with Biotech and SynBio to experiment […]

October 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Oct 2016

Do we hear a Tinnitus Cure? This techno-loving CEO might have one…

It’s Friday, and here in Berlin, we’re ready for the club. A German company, Sonormed, is developing an app that can reduce the consequent ringing in our ears. Sonormed’s co-founder and CEO, Jörg Land, loves techno, and he started a company to help his fellow beat lovers with their common affliction of tinnitus. His soon-to-be […]

October 7, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 7 Oct 2016

Meet the ‘Haut-Couturiers’ of Bioengineering

It’s time to ride the slopes and land in the French alpine capital, Grenoble, to meet our Biotech of the week, BGene Genetics. This start-up is changing the bug factory sector! BGene has developed a method to edit the chromosomes of a bug to produce proteins rather than inserting a plasmid, and this proprietary technology […]

October 7, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 7 Oct 2016

Will SynBio replace the French Wine Industry?

Ava Winery is creating cheap, sustainable and customizable wine without grapes, yeast or fermentation. The company plans to commercialize its first product in the coming months, will they be able to steal customers from the most famous French wine companies? Ava Winery claims that 90% of tasters cannot tell its prototype apart from traditional wine. The […]

October 7, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Oct 2016

NASH Maverick continues Rampage with €34M Cash Injection

Genfit just added €34M to its cash pile through private placement to bankroll the development of its succeeding lead candidate, Elafibranor. Genfit has had a good year. Earlier this year, the company enrolled its first patient in Phase III clinical trails for Non-Alcoholic Stato-Hepatitis (NASH), and last month, it launched a new non-invasive diagnostic program. It’s […]

October 6, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 6 Oct 2016

New UK Hero Will Fight Against Non-Small Cell Lung Cancer

Achilles Therapeutics was born yesterday in the UK with a €15M funding round. The company will focus on the development of personalized neo-antigentherapies for non-small lung cancer. The newborn Achilles Therapeutics made its debut yesterday with a splashy fundraising round and a licensing agreement. The startup has exclusive rights to develop and commercialize any neo-antigen technology that […]

October 6, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

World Mental Health Day: How is Biotech Helping the Cause?

Big Pharmas Battle to be the Lung Cancer Leader at ESMO

Overseas Deaths in the Clinic come as a Blow to Boehringer Ingelheim

The CRISPR Revolution is here, but how can we make it Useful?

Meet the French CEO who wants to Break Barriers to Drug Delivery

Microbial Donuts at the Vienna Design Week, fancy a bite? Here’s the Recipe!

Do we hear a Tinnitus Cure? This techno-loving CEO might have one…

Meet the ‘Haut-Couturiers’ of Bioengineering

Will SynBio replace the French Wine Industry?

NASH Maverick continues Rampage with €34M Cash Injection

New UK Hero Will Fight Against Non-Small Cell Lung Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!